Axol’s iPSC-derived cardiomyocytes are CiPA-validated, making them the perfect model for cardiotoxicity assays.
Transform Your Assays With Human iPSCs
Assay Development scientists around the world are using iPSCs for innovative research
Quality, robust human iPSC-derived cells for assays
Axol’s human iPSC-derived cells are manufactured under stringent quality control management systems. Our ready-to-ship cells are robust, and reliable and offer Assay Development scientists an opportunity to transform their assays with physiologically relevant scenarios.
You can also leverage our expertise and assay capabilities at Axol. We offer a suite of custom research services on top of our iPSC technological development skills. Reach out to us to learn more